Winston Pharmaceuticals
Winston Pharmaceuticals, Inc.
100 N. Fairway Drive, Suite 134
Vernon Hills, IL 60061
T: (847) 362-8200
F: (847) 362-8394
info@winstonlabs.com
Norton 360
Welcome
Welcome to the web site of Winston Pharmaceuticals, The Pain Company®!

Winston Pharmaceuticals is a specialty pharmaceutical company that discovers, develops, and commercializes innovative therapeutics for managing and alleviating pain. The company’s guiding objective is to reduce needless suffering and improve substantially the quality of life for people with pain.

In its various manifestations, pain afflicts tens of millions of individuals—far too many of whom cannot obtain adequate relief from existing treatments. In recent years, the medical community has intensified its efforts to diagnose and treat pain with greater success. Winston Pharmaceuticals is working to advance this critical cause by developing unique, safe, and effective therapies for pain management.

Press Releases
 
April 9th, 2012
Winston Pharmaceuticals, Inc. Receives SBIR Grant from the NIH to Investigate Treatment for Postherpetic Neuralgia of the Trigeminal Nerve
 
November 22nd, 2010
Winston Pharmaceuticals, Inc. Announces Positive Results of Phase II Clinical Trial of Dolorac® Nasal Solution
 
November 10th, 2010
Winston Pharmaceuticals Inc  To Present at Lazard Capital Markets 7th Annual Healthcare Conference
 
July 20th, 2010
Winston Laboratories, Inc. Receives Notice of Compliance in Canada for CIVANEX (Civamide Cream) for Treatment of Osteoarthritis
 
July 7th, 2010
Winston Laboratories, Inc. Submits NDA for Civanex (Civamide Cream) for treatment of Osteoarthritis
 
November 16, 2009
Winston Laboratories, Inc. Announces Positive Top-line Results of Phase II 
 
November 10, 2009
Winston Pharmaceuticals, Inc. To Present at Lazard Capital Markets 6th Annual Healthcare Conference 
 
October 19, 2009
Winston Laboratories, Inc. Receives Notice of Non-Compliance in Canada for its New Drug Submission of CIVANEX to Treat Osteoarthritis 
 
August 14, 2009
Winston Pharmaceuticals, Inc. Announces Re-Election of Joel E. Bernstein M.D. as President and Chief Executive Officer
 
July 28, 2009
Winston Pharmaceuticals, Inc. Announces Election of New Chief Executive Officer and Chairman of the Board of Directors
 
February 24, 2009
Winston Pharmaceuticals, Inc. Receives Orphan Drug Designation for Novel Patch to Treat Post-Herpetic Neuralgia
 
February 9, 2009
Winston Pharmaceuticals, Inc. Announces Positive Top-line Results of Phase I Clinical Trial of Civamide Patch
 
January 15, 2009
Winston Pharmaceuticals, Inc. (Formerly Getting Ready Corporation) commences trading under new name and stock symbol
 
View all Press Releases
Copyright © 2009. WINSTON PHARMACEUTICALS, Inc. All Rights Reserved.
Terms of Use....